Related Experiment Video
Updated: Jul 10, 2026
05:39
Non-Intubated Video-Assisted Thoracoscopic Surgery
Published on: May 26, 2023
Postoperative pneumonia after major pulmonary resections: an unsolved problem in thoracic surgery
Dana M Radu1, Françoise Jauréguy, Agathe Seguin
1Department of Thoracic and Vascular Surgery, Avicenne Hospital, Bobigny, France. danabudescu@gmail.com
The Annals of Thoracic Surgery
|October 24, 2007
Summary
Current antibiotic prophylaxis for thoracic surgery is ineffective against common pneumonia pathogens. New approaches are needed to prevent postoperative infections after lung resections.
Area of Science:
- Medical microbiology
- Thoracic surgery
- Infectious disease
Background:
- First- and second-generation cephalosporins are standard prophylactic antibiotics in thoracic surgery.
- Postoperative pneumonia remains a frequent and severe complication after major pulmonary resections.
- The origins of these infections are poorly documented in existing literature.
Purpose of the Study:
- To evaluate the effectiveness of current antibiotic prophylaxis regimens.
- To identify pathogens responsible for postoperative pneumonia after major pulmonary resections.
- To assess antibiotic susceptibility of isolated microorganisms.
Main Methods:
- Retrospective analysis of 312 major pulmonary resection cases (January 2000 - December 2004).
- Microbiologic analysis of agents and antibiotic susceptibility for patients with postoperative pulmonary infection.
- Documentation of pathogens and their resistance patterns.
Main Results:
- Postoperative pneumonia occurred in 24.4% of patients, with 78.9% of infections appearing within 5 days.
- Key pathogens identified included Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus spp., and Enterobacteriaceae.
- Cefazolin prophylaxis was ineffective in 84% of microbiologically documented cases based on antibiotic susceptibility.
Conclusions:
- Current prophylactic antibiotic regimens are inefficient against pathogens causing postoperative pneumonia after lung resections.
- There is a critical need for new, more effective antibiotic prophylaxis strategies.
- Prospective, multicenter trials are recommended to evaluate novel approaches.
Related Concept Videos
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.